Epidemiology Practice Questions

Q: Which statement is not true regarding cross-sectional studies?

Is useful for studying acute diseases.. **Explanation:** **1. Why Option D is the correct (False) statement:** Cross-sectional studies are often referred to as **"Prevalence Studies"** or "Snapshot Studies." They measure the exposure and outcome simultaneously at a single point in time. Because they capture only a "snapshot," they are unsuitable for studying **acute diseases** (diseases with short durations, like the common cold or cholera). By the time a cross-sectional survey is conducted, patients with acute illnesses have either recovered or succumbed, making them unlikely to be captured in the sample. These studies are best suited for **chronic conditions** (e.g., Hypertension, Diabetes) where the disease persists over time. **2. Analysis of Incorrect Options:** * **Option A (True):** Since the study identifies all existing cases at a specific point in time, it directly measures **Prevalence**. * **Option B (True):** Incidence refers to *new* cases occurring over a period. Since there is no follow-up (temporal dimension) in a cross-sectional design, it **cannot measure incidence**. * **Option C (True):** Because there is no long-term follow-up or repeated visits (unlike longitudinal/cohort studies), cross-sectional studies are significantly **faster and less expensive**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Temporal Ambiguity:** The biggest limitation of cross-sectional studies is the "chicken or egg" dilemma—it is impossible to determine if the exposure preceded the outcome. * **Neyman Bias (Prevalence-Incidence Bias):** Cross-sectional studies over-represent chronic/stable cases and under-represent acute/fatal cases. * **Sequence of Study Designs:** Often used as the first step in investigating an association before progressing to Case-Control or Cohort studies.

Q: In a population of 5000, the incidence of a disease is 100 cases in 1 year. The duration of the disease studied is 2 years. Calculate the prevalence.

40/1000. ### **Explanation** The core concept tested here is the mathematical relationship between **Incidence, Prevalence, and Duration** of a disease. #### **1. Why Option B is Correct** For stable diseases with low frequency, the relationship is expressed by the formula: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D)** * **Step 1: Calculate Incidence (I)** Incidence = (New cases / Total population) = 100 / 5,000. * **Step 2: Identify Duration (D)** Duration = 2 years. * **Step 3: Apply the Formula** P = (100 / 5,000) × 2 P = 200 / 5,000 P = 40 / 1,000 Thus, the prevalence is **40 per 1,000 population**. #### **2. Why Other Options are Incorrect** * **Option A (20/1000):** This represents only the annual incidence (100/5000). It fails to account for the 2-year duration during which cases accumulate. * **Option C (80/1000):** This is a calculation error, likely from doubling the correct prevalence or misapplying the denominator. * **Option D (400/1000):** This is a decimal error (off by a factor of 10), representing a 40% prevalence, which is inconsistent with the data provided. #### **3. NEET-PG High-Yield Pearls** * **Definitions:** Incidence measures **new cases** (indicator of risk/etiology); Prevalence measures **all current cases** (indicator of burden/administrative planning). * **Factors increasing Prevalence:** Longer duration of disease, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Factors decreasing Prevalence:** Shorter duration, high case fatality rate, improved cure rate, and out-migration. * **Rule of Thumb:** If a disease is highly fatal or easily cured, its prevalence will be low even if the incidence is high.

Q: Which of the following is NOT an example of a disease exhibiting a cyclical trend of occurrence?

Polio. ### Explanation In epidemiology, **cyclical trends** refer to the recurrent fluctuations in disease incidence over short periods (usually 2–3 years or more). These cycles are typically driven by the buildup of a critical mass of susceptible individuals in a population (herd immunity threshold). **Why Polio is the Correct Answer:** Polio does not exhibit a cyclical trend; instead, it follows a **seasonal trend**. Historically, polio incidence peaked during the summer and early autumn months in temperate climates. Furthermore, due to the Global Polio Eradication Initiative and intensive vaccination (Pulse Polio), the natural transmission cycles have been disrupted, moving the disease toward elimination rather than periodic cycles. **Analysis of Incorrect Options:** * **Measles:** Classically exhibits a 2–3 year cycle in the pre-vaccination era. As new births occur, the pool of susceptible children grows until it reaches a threshold that triggers an epidemic. * **Rubella:** Historically shows a cyclical pattern every 6–9 years. Like measles, it depends on the accumulation of non-immune individuals. * **Influenza:** Exhibits both seasonal trends (annual winter peaks) and cyclical trends (pandemics occurring every 10–40 years due to major antigenic shifts). **High-Yield NEET-PG Pearls:** * **Secular Trend:** Long-term changes (years/decades) in disease occurrence (e.g., the rise of Diabetes or the decline of TB). * **Cyclical Trend:** Short-term periodic fluctuations (e.g., Measles: 2–3 years; Rubella: 6–9 years). * **Seasonal Trend:** Fluctuations within a single year (e.g., GI infections in summer, Respiratory infections in winter). * **Point Source Epidemic:** All cases occur within one incubation period (e.g., Food poisoning).

Q: In which year was the first reliable census conducted in India?

1881. ### Explanation **1. Why Option A is Correct:** The first **synchronous (reliable and complete)** census in India was conducted in **1881** under the British administration (Lord Ripon). While an initial attempt at a census was made in 1872 (under Lord Mayo), it was non-synchronous and did not cover the entire country simultaneously. The 1881 census established the standard for the decennial (every 10 years) census system that continues today, making it the benchmark for reliable demographic data collection in India. **2. Why Other Options are Incorrect:** * **Option B (1951):** This was the **first census of Independent India**. It is significant for post-independence planning but not the "first reliable" one in historical terms. * **Option C (1981):** This was the 12th census in the series. It is notable for being the first to include questions on "reasons for migration," but it holds no "first" status regarding reliability. * **Option D (2001):** This was the first census of the 21st century. It is historically distant from the origin of the Indian census system. **3. High-Yield Facts for NEET-PG:** * **Census Frequency:** Conducted every **10 years** (Decennial) under the Census Act, 1948. * **The "Great Divide":** The year **1921** is known as the "Year of the Great Divide" because it was the only census year where India recorded a negative population growth rate. * **Census Method:** India primarily uses the **"Extended De Facto"** method (canvassing over a period, with a reference date). * **Authority:** The census is conducted by the **Registrar General and Census Commissioner of India** under the Ministry of Home Affairs. * **2011 Census Fact:** The mascot was a "Female Enumerator," and the slogan was "Our Census, Our Future."

Q: Acute flaccid paralysis is reported in a child aged:

0-15 years. ### Explanation **1. Why 0-15 years is the Correct Answer:** Under the **Global Polio Eradication Initiative**, Acute Flaccid Paralysis (AFP) surveillance is the gold standard for detecting cases of poliomyelitis. The operational definition for AFP surveillance includes any child **under 15 years of age** who presents with a sudden onset of flaccid weakness or paralysis. This age group is targeted because children under 15 are biologically most susceptible to paralytic poliomyelitis. Additionally, any person of any age must be reported if a clinician strongly suspects polio. **2. Analysis of Incorrect Options:** * **A (0-3 years) & B (3-5 years):** While younger children are at the highest risk for contracting polio (often called "infantile paralysis"), limiting surveillance to these ages would result in missing a significant number of cases in older children, thereby failing to detect circulating poliovirus in the community. * **D (15-19 years):** While adolescents can technically contract polio, they are not the primary target for routine AFP surveillance protocols unless there is a high clinical suspicion. **3. NEET-PG High-Yield Clinical Pearls:** * **AFP Surveillance Criteria:** A sensitive surveillance system must detect at least **3 cases of non-polio AFP per 100,000 children** under 15 years of age annually (in India). * **Specimen Collection:** To confirm or rule out polio, **two "adequate" stool samples** must be collected 24–48 hours apart, within 14 days of the onset of paralysis. * **The "60-Day" Rule:** All AFP cases must be followed up at 60 days from the onset of paralysis to check for residual paralysis, which is a hallmark of paralytic polio. * **Differential Diagnosis for AFP:** The most common cause of non-polio AFP is **Guillain-Barré Syndrome (GBS)**.

Q: A new drug does not prevent a disease from occurring but reduces death due to that disease. Which of the following is true?

Prevalence is increased. ### Explanation This question tests the fundamental understanding of the relationship between **Incidence**, **Prevalence**, and **Disease Duration**. #### 1. Why the Correct Answer is Right The core concept here is the formula: **Prevalence (P) = Incidence (I) × Mean Duration of disease (D)**. * **Incidence** refers only to *new* cases. Since the drug does not prevent the disease from occurring, the rate of new cases remains unchanged. * **Prevalence** refers to *all* existing cases (new + old) at a given time. * By reducing deaths, the drug ensures that patients live longer with the disease. This increases the **duration (D)** of the illness. As patients stay in the "prevalent pool" longer instead of leaving it through death, the total number of existing cases (**Prevalence**) increases. #### 2. Why Other Options are Wrong * **Option A & D (Incidence is increased):** Incidence is affected by preventive measures (vaccines, lifestyle changes). Since this drug is a treatment that doesn't prevent occurrence, it has no impact on the number of new cases. * **Option B (Decrease incidence and prevalence):** This would only happen if the drug was a primary preventive measure (decreasing incidence) or a rapid cure (decreasing duration/prevalence). #### 3. High-Yield Clinical Pearls for NEET-PG * **Prevalence** is increased by: Longer duration of disease, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Prevalence** is decreased by: Shorter duration of disease, high case fatality rate (death), rapid cure, and out-migration of cases. * **Incidence** is the best indicator for **etiology** (causation) and the effectiveness of **primary prevention**. * **Prevalence** is most useful for **administrative purposes** and healthcare planning (e.g., estimating the number of hospital beds needed).

Q: In a case-control study, how is the association between a disease and a risk factor primarily assessed?

Odds ratio. ### Explanation In epidemiology, the choice of association measure depends entirely on the study design. **Why Odds Ratio (OR) is correct:** A **Case-Control study** starts with the outcome (disease) and looks backward to determine exposure. Because the researcher determines the number of cases and controls at the start, the true **incidence** of the disease cannot be calculated. Since Relative Risk requires incidence data, it cannot be used. Instead, we use the **Odds Ratio**, which estimates the odds of exposure among cases compared to the odds of exposure among controls. It serves as a reliable proxy for Relative Risk when the disease is rare. **Why other options are incorrect:** * **A. Relative Risk (RR):** This is the primary measure for **Cohort studies**. It requires the calculation of incidence (new cases over time), which is only possible in prospective designs where we follow exposed and non-exposed groups. * **B. Attributable Risk (AR):** This measures the amount of disease incidence that can be attributed to a specific exposure. Like RR, it requires **incidence rates** from a cohort study. * **C. Population Attributable Risk (PAR):** This indicates how much of the disease in the total population would be eliminated if the exposure were removed. It also relies on incidence data. **High-Yield Clinical Pearls for NEET-PG:** * **Case-Control Study:** Retrospective, fast, inexpensive, and ideal for **rare diseases**. * **Cohort Study:** Prospective, expensive, time-consuming, and ideal for **rare exposures**. * **Odds Ratio Formula:** $ad / bc$ (Cross-product ratio from a 2x2 table). * **Matching:** A technique used in Case-Control studies to eliminate **confounding bias**. * **Recall Bias:** The most common type of bias encountered in Case-Control studies.

Question 1

Which statement is not true regarding cross-sectional studies?

Accepted Answer

Is useful for studying acute diseases.

Answer

Prevalence can be measured.

Answer

Does not provide information about incidence.

Answer

Is less expensive compared to longitudinal studies.

Question 2

In a population of 5000, the incidence of a disease is 100 cases in 1 year. The duration of the disease studied is 2 years. Calculate the prevalence.

Accepted Answer

40/1000

Answer

20/1000

Answer

80/1000

Answer

400/1000

Question 3

Which of the following is NOT an example of a disease exhibiting a cyclical trend of occurrence?

Accepted Answer

Polio

Answer

Measles

Answer

Rubella

Answer

Influenza

Question 4

In which year was the first reliable census conducted in India?

Accepted Answer

1881

Answer

1951

Answer

1981

Answer

2001

Question 5

Which of the following is an example of primordial prevention?

Accepted Answer

Prevention of the emergence or development of risk factors.

Answer

Action taken prior to the onset of disease.

Answer

Action taken to remove the possibility that a disease will ever occur.

Answer

Action that halts the progress of a disease.

Question 6

In a study of 500 patients with viral fever, 80 percent were cured within 3 days after receiving a certain medicine. Which statement accurately reflects the efficacy of this medicine based on this data?

Accepted Answer

The efficacy of the medicine cannot be definitively commented on.

Answer

The medicine is definitively effective.

Answer

The medicine is ineffective.

Answer

None of the above.

Question 7

Which of the following are included in the surveillance definition for AIDS?

Accepted Answer

Extrapulmonary TB, Cryptococcosis, Candidiasis, Kaposi sarcoma

Answer

Extrapulmonary TB, Cryptococcosis, Candidiasis, Leptospirosis

Answer

Extrapulmonary TB, Candidiasis, Leptospirosis, Kaposi sarcoma

Answer

Extrapulmonary TB, Cryptococcosis, Leptospirosis, Kaposi sarcoma

Question 8

Acute flaccid paralysis is reported in a child aged:

Accepted Answer

0-15 years

Answer

0-3 years

Answer

3-5 years

Answer

15-19 years

Question 9

A new drug does not prevent a disease from occurring but reduces death due to that disease. Which of the following is true?

Accepted Answer

Prevalence is increased

Answer

It will increase the incidence and prevalence

Answer

It will decrease the incidence and prevalence

Answer

Incidence is increased

Question 10

In a case-control study, how is the association between a disease and a risk factor primarily assessed?

Accepted Answer

Odds ratio

Answer

Relative risk

Answer

Attributable risk

Answer

Population attributable risk

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?